Family & General Practitioners

Sumanta Kuma Pal, MD

City of Hope - Main Campus (Duarte) · Duarte, CA

No doctor has been recommended in Family & General Practice in Duarte, CA this month. The first recommendation takes the lead for Top Doctor of the Month. See the race →

Recommend This Doctor

Identity verified on September 21, 2026 · Listed since 2015

Are you Dr. Pal? Sign in to update your profile

1 Doctor Endorsement

5.0

Recommend This Doctor

Has endorsed Dr. Dorrie E. Chang and Dr. Dana L. Tarcatu.

What colleagues highlight

Great colleaguein 1 endorsement

April 27, 2015
“I had the pleasure to work collaboratively, as a Palliative Care consultant, with Dr. Pal at City of Hope. Despite his young age, he is already an accomplished academician with an impressive portfolio. He is very much loved and appreciated by his patients and colleagues. His passion to learn and share knowledge make him a great teacher and mentor to his fellows, who are very lucky to have him as a role model.”
Dr. Dana TarcatuInternal Medicine, Hospice and Palliative Medicine · New York, NY

About

Sumanta Kumar Pal, M.D., is an assistant professor in the Department of Medical Oncology & Therapeutics Research and co-director of the Kidney Cancer Program at City of Hope. Read more

Sumanta Kumar Pal, M.D., is an assistant professor in the Department of Medical Oncology & Therapeutics Research and co-director of the Kidney Cancer Program at City of Hope. Having been appointed to the faculty for just over four years, Dr. Pal has been extremely productive, publishing more than 80 manuscripts in peer-reviewed journals. He has presented his work in multiple international meetings.

2006-present, American Society of Clinical Oncology (ASCO) (2006- present)

National Comprehensive Cancer Network Bladder Cancer Committee (2010-present)

HER2-Positive Breast Cancer Committee, ASCO (2012-2013)

Genitourinary Cancers Committee, ASCO (2013-present )

Location

City of Hope - Main Campus (Duarte)Duarte, CA

DCA Awards

No Doctors’ Choice Awards yet.